ArticleBMC medicine2025

Assessing the representativeness of trials of Sodium-glucose Cotransporter-2 inhibitors in type 2 diabetes: a comparison of individual-level trial data and people newly prescribed treatment in a Welsh routine care database.

Peter Hanlon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.